https://www.selleckchem.com/pr....oducts/sch-900776.ht
Avoiding phosphate loading, restricting calcium-based phosphate binders and high doses of vitamin D, and avoiding normalizing (within the normal limits for the assay) parathyroid hormone levels seem logical approaches. The availability of new drugs and future studies, including patients in early stages of CKD, may lead to significant improvements not only in patient risk stratification but also in attenuating the accelerated progression of VC in CKD.Common carotid intima-media thickness (IMT) represents a functional and structural ma
Like
Comment
Share
